HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Teeru Bihani Selected Research

RAD1901

12/2019Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors.
10/2019EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer.
8/2017Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER+ Breast Cancer Patient-derived Xenograft Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Teeru Bihani Research Topics

Disease

10Breast Neoplasms (Breast Cancer)
08/2023 - 12/2012
8Neoplasms (Cancer)
08/2023 - 01/2007
1Circulating Neoplastic Cells
08/2023
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2014
1Carcinogenesis
12/2012

Drug/Important Bio-Agent (IBA)

8Estrogen ReceptorsIBA
08/2023 - 11/2015
5elacestrantIBA
08/2023 - 08/2017
5Fulvestrant (Faslodex)FDA Link
08/2023 - 11/2015
3RAD1901IBA
12/2019 - 08/2017
3EverolimusFDA Link
08/2017 - 02/2015
2Aromatase InhibitorsIBA
10/2019 - 11/2015
2Estrogen Receptor Modulators (Antiestrogen)IBA
01/2018 - 08/2017
2palbociclibIBA
08/2017 - 08/2016
2Mechanistic Target of Rapamycin Complex 1IBA
11/2015 - 07/2014
1Hormones (Hormone)IBA
08/2023
1Biomarkers (Surrogate Marker)IBA
01/2018
1Selective Estrogen Receptor Modulators (SERM)IBA
01/2018
1VorinostatFDA Link
08/2016
1vistusertibIBA
11/2015
1MTOR InhibitorsIBA
11/2015
1Mechanistic Target of Rapamycin Complex 2IBA
11/2015
1matrigelIBA
02/2015
1Estrogens (Estrogen)FDA Link
02/2015
1Cyclin D1IBA
12/2012
1Phosphotransferases (Kinase)IBA
12/2012
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2007
1Small Interfering RNA (siRNA)IBA
01/2007

Therapy/Procedure

8Therapeutics
08/2023 - 07/2014
1Drug Therapy (Chemotherapy)
07/2014